The Effects of a Pharmacist-led Medication Review in a Nursing Home: A Randomized Controlled Trial

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2022 Jan 20

PMID 35049214

Authors

Wen-Shyong Liou

Shih-Ming Huang

Wei-Hsin Lee

Yen-Lin Chang

Ming-Fen Wu

Affiliations

Soon will be listed here.

Abstract

Background: In this study, an intensive review of pharmaceutical care for elderly patients was conducted in a Veterans Administration nursing home in Taiwan and its effects were evaluated.

Methods: One hundred participants were enrolled in this randomized controlled study with even distribution. The inclusion criteria were age 65 years or older, prescriptions for at least 5 oral medicines daily, and ≥2 chronic diseases, for the period May 2013 to October 2014. Subjects were excluded if they had previously been included in an intensive medication review conducted by a pharmacist. The primary outcomes were numbers of drugs prescribed, potential inappropriate medications, and numbers of drug-related problems. The secondary outcomes were self-reported medical usages, measurements of quality of life, results of a satisfaction survey, and health status.

Results: A total of 80 cases (42 in the intervention group with medication reconciliation and 38 in the control group without medication reconciliation) completed the study. Baseline characteristics were not statistically different between the 2 groups. The overall prevalence of potential inappropriate medication was 74.3%. There were no differences between the 2 groups, with the exception of "medical problems," which showed a significantly higher prevalence in the intervention group (P < .05). The intervention group reported greater satisfaction regarding pharmacist visits and medication compliance (P < .01). The mean number of drug-related problems was significantly lower after the intervention (P < .01).

Conclusion: In this study, the intensive review of the elderly patients' medications revealed that the only significant effect of pharmaceutical care was on "all outcomes." A possible reason for this is the rather advanced ages of some patients who needed a considerable number of medications to treat several chronic diseases. Another reason may be the small sample size. However, participants who received the pharmacist intervention did have higher satisfaction with medication reconciliation and fewer drug-related problems.

Citing Articles

The pharmacists' interventions after a Drug and Therapeutics Committee (DTC) establishment during the COVID-19 pandemic.

Kassem A, Al Meslamani A, Elmaghraby D, Magdy Y, Abdelrahman M, Hamdan A J Pharm Policy Pract. 2024; 17(1):2372040.

PMID: 39011356 PMC: 11249153. DOI: 10.1080/20523211.2024.2372040.

Pharmacist interventions in Asian healthcare environments for older people: a systematic review and meta-analysis on hospitalization, mortality, and quality of life.

Kim I, Ryu G, Rhie S, Kim H BMC Geriatr. 2024; 24(1):513.

PMID: 38867148 PMC: 11170896. DOI: 10.1186/s12877-024-05089-9.

Measuring Quality of Life in Deprescribing Trials: A Scoping Review.

Thompson W, Lundby C, Bleik A, Waring H, Hong J, Xi C Drugs Aging. 2024; 41(5):379-397.

PMID: 38709466 DOI: 10.1007/s40266-024-01113-0.

The Impact of Pharmacist Medication Reviews on Geriatric Patients: A Scoping Review.

Yaacob N, Loganathan M, Hisham N, Kamaruzzaman H, Isa K, Ibrahim M Korean J Fam Med. 2024; 45(3):125-133.

PMID: 38583876 PMC: 11116121. DOI: 10.4082/kjfm.23.0220.

Frequency and impact of medication reviews for people aged 65 years or above in UK primary care: an observational study using electronic health records.

Joseph R, Knaggs R, Coupland C, Taylor A, Vinogradova Y, Butler D BMC Geriatr. 2023; 23(1):435.

PMID: 37442984 PMC: 10347807. DOI: 10.1186/s12877-023-04143-2.

References

Reich O, Rosemann T, Rapold R, Blozik E, Senn O . Potentially inappropriate medication use in older patients in Swiss managed care plans: prevalence, determinants and association with hospitalization. PLoS One. 2014; 9(8):e105425. PMC: 4138178. DOI: 10.1371/journal.pone.0105425. View

Patterson S, Cadogan C, Kerse N, Cardwell C, Bradley M, Ryan C . Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2014; (10):CD008165. DOI: 10.1002/14651858.CD008165.pub3. View

Furniss L, Burns A, Craig S, Scobie S, Cooke J, Faragher B . Effects of a pharmacist's medication review in nursing homes. Randomised controlled trial. Br J Psychiatry. 2000; 176:563-7. DOI: 10.1192/bjp.176.6.563. View

Beers M, Ouslander J, Rollingher I, Reuben D, Brooks J, Beck J . Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991; 151(9):1825-32. View

Saez-Benito L, Fernandez-Llimos F, Feletto E, Gastelurrutia M, Martinez-Martinez F, Benrimoj S . Evidence of the clinical effectiveness of cognitive pharmaceutical services for aged patients. Age Ageing. 2013; 42(4):442-9. DOI: 10.1093/ageing/aft045. View

Ruiz-Millo O, Climente-Marti M, Navarro-Sanz J . Improvement on prescribing appropriateness after implementing an interdisciplinary pharmacotherapy quality programme in a long-term care hospital. Eur J Hosp Pharm. 2019; 25(5):267-273. PMC: 6452358. DOI: 10.1136/ejhpharm-2017-001411. View

Anderegg S, DeMik D, Carter B, Dawson J, Farris K, Shelsky C . Acceptance of recommendations by inpatient pharmacy case managers: unintended consequences of hospitalist and specialist care. Pharmacotherapy. 2013; 33(1):11-21. PMC: 4117375. DOI: 10.1002/phar.1164. View

Sorensen L, Stokes J, Purdie D, Woodward M, Elliott R, Roberts M . Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol. 2004; 58(6):648-64. PMC: 1884656. DOI: 10.1111/j.1365-2125.2004.02220.x. View

Alassaad A, Bertilsson M, Gillespie U, Sundstrom J, Hammarlund-Udenaes M, Melhus H . The effects of pharmacist intervention on emergency department visits in patients 80 years and older: subgroup analyses by number of prescribed drugs and appropriate prescribing. PLoS One. 2014; 9(11):e111797. PMC: 4218816. DOI: 10.1371/journal.pone.0111797. View

10.

Juanes A, Garin N, Mangues M, Herrera S, Puig M, Faus M . Impact of a pharmaceutical care programme for patients with chronic disease initiated at the emergency department on drug-related negative outcomes: a randomised controlled trial. Eur J Hosp Pharm. 2019; 25(5):274-280. PMC: 6452329. DOI: 10.1136/ejhpharm-2016-001055. View

11.

Bradley M, Motterlini N, Padmanabhan S, Cahir C, Williams T, Fahey T . Potentially inappropriate prescribing among older people in the United Kingdom. BMC Geriatr. 2014; 14:72. PMC: 4091750. DOI: 10.1186/1471-2318-14-72. View

12.

Van der Linden L, Hias J, Dreessen L, Milisen K, Flamaing J, Spriet I . Medication review versus usual care to improve drug therapies in older inpatients not admitted to geriatric wards: a quasi-experimental study (RASP-IGCT). BMC Geriatr. 2018; 18(1):155. PMC: 6029069. DOI: 10.1186/s12877-018-0843-y. View

13.

Riordan D, Aubert C, Walsh K, van Dorland A, Rodondi N, Du Puy R . Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study. BMJ Open. 2018; 8(3):e019003. PMC: 5875647. DOI: 10.1136/bmjopen-2017-019003. View

14.

. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012; 60(4):616-31. PMC: 3571677. DOI: 10.1111/j.1532-5415.2012.03923.x. View

15.

Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K . Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol. 2015; 71(12):1415-27. DOI: 10.1007/s00228-015-1954-4. View

16.

Dalleur O, Boland B, Losseau C, Henrard S, Wouters D, Speybroeck N . Reduction of potentially inappropriate medications using the STOPP criteria in frail older inpatients: a randomised controlled study. Drugs Aging. 2014; 31(4):291-8. DOI: 10.1007/s40266-014-0157-5. View

17.

Gao L, Maidment I, Matthews F, Robinson L, Brayne C . Medication usage change in older people (65+) in England over 20 years: findings from CFAS I and CFAS II. Age Ageing. 2017; 47(2):220-225. PMC: 6037294. DOI: 10.1093/ageing/afx158. View

18.

Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson P, Carpenter I . Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005; 293(11):1348-58. DOI: 10.1001/jama.293.11.1348. View

19.

Wu Y, Chen C, Wu T . Geriatric polypharmacy in Taiwan. J Formos Med Assoc. 2015; 115(11):891-892. DOI: 10.1016/j.jfma.2015.08.003. View

20.

Landi F, Russo A, Liperoti R, Barillaro C, Danese P, Pahor M . Impact of inappropriate drug use on physical performance among a frail elderly population living in the community. Eur J Clin Pharmacol. 2007; 63(8):791-9. DOI: 10.1007/s00228-007-0321-5. View